Table
of Contents
|
FDA Clears First Diagnostic Blood Test for Congestive Heart Failure |
FDA Clears Home Cholesterol Monitor With Smart Card Technology |
FDA Clears AvoSure PT System for Consumer Use to Measure Blood Clotting Time |
PharmChek Patch Available for Use in Fight Against Drugs of Abuse |
FDA Clears New Diagnostic Test For Helicobacter pylori |
New Handheld Computers to Track Patient Pain Over Time |
FDA Clears New Diagnostic Test to Detect Recurrent Bladder Cancer |
FDA Clears New Diabetes Management System |
FDA Clears New Test to Detect Amphetamines Including Ecstacy |
FDA
Clears Noninvasive Screening System for Cardiovascular
Disease |
FDA Approves GERD Monitoring System |
FDA Clears Vasotrax Handheld Blood Pressure Monitor |
FDA Grants Clearance to Careside, Inc.’s Hemoglobin and Hematocrit |
Point-of-Care Blood TestsFDA Clears UriSite Urine Collection Kit for Microalbumin/Creatine Testing |
Identify Bacteria With the OnSite Urine Culture Device |
New Pepsinogen-1 Test Aids in the Detection of Peptic Ulcers and Gastric Caricoma |
FDA Clears New Blood Glucose Monitoring System |
FDA Grants Clearance to Metrika Inc.’s Digital Response® (DRx®) HbA1c
Patient Monitor |
FDA Grants Clearance to Qualigen Inc.’s FastPack Point-of-Care Blood Testing System |
New Dade Behring Diagnostic Test for Thrombosis |
At Home Prostate Disease Test |
Bayer Diagnostics Low Range Heparin Management Test |
FDA Clears Careside Inc.’s Point of Care Direct Bilirubin Test |
FDA Clears Trinity Biotech PLC
Uni-Gold H. pylori Immunoassay |
FDA Clears Quantech Ltd Human Chorionic Gonadotropin Pregnancy Test |
FDA Clears Digene Corp.’s Hybrid Capture II Test for Detecting Neisseria Gonorrhea |